By Ben James ( February 14, 2008, 12:00 AM EST) -- Novartis International AG now has two patent suits pending against generics maker Teva Pharmaceuticals USA Inc. over the blockbuster hypertension drug Lotrel, lodging a new complaint after Teva submitted a bid to make its proposed generic in different dosage strengths....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.